The insulin pump world is still stinging over Johnson and Johnson (NYSE: JNJ) decision to shut down Animas. Judging by the reaction on social media there are some very unhappy campers out in insulin pump land. There is also a bunch of misinformation, conjuncture and conspiracies about why JNJ did what they did. We don’t blame these people for being ticked as their lives have been just been tuned upside down. However, the target of their displeasure should not be JNJ or Medtronic (NYSE: MDT), who is being unfairly blamed for Animas demise.
Sorry but we just cannot let . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.